🔍
GLOW Pro research peptide blend vial and box
GLOW (BPC-157 + GHK-Cu + TB-500) Pro
  1. GLOW Pro research peptide blend vial and box
  2. GLOW (BPC-157 + GHK-Cu + TB-500) Pro

GLOW (BPC-157 + GHK-Cu + TB-500) Pro

Pro Series
A three-component lyophilized blend of BPC-157, GHK-Cu and TB-500
BlendLyophilized powder

Price range: $179.00 through $1,599.00

Ships from lot NHS-GLW70-20260831-01 · 70 mg vial · 99% purity · pH Solutions Lab See the COA
Why the Pro Series costs more
  • Synthesized in the USA. Domestic ground and air only, no ocean freight.
  • Released only above 99% HPLC purity.
  • Its own lot and its own published certificate.
How the Pro Series is made and tested
Ships from Austin, TexasUnited States only
Tested by an outside labNever in-house
Every lot publishedIncluding rejected lots
Same-day dispatchOn orders before 2pm ET
SKU: N/A Category: Tags: ,
BATCH
VERIFICATION
LOT NUMBER
NHS-GLW70-20260831-01
70 mg vial
IDENTITY
Match: GHK-Cu (C14H24CuN6O4, 403.9 g/mol), BPC-157 (C62H98N16O22, 1419.5 g/mol), TB-500 (C212H350N56O78S, 4963.4 g/mol)
CHROMATOGRAPHIC PURITY
99%
NET CONTENT (TOTAL)
70.7063 mg (101.009% of 70 mg nominal: GHK-Cu 50 mg, BPC-157 10 mg, TB-500 10 mg)
Analytical characterization

Every result against its specification.

Lot NHS-GLW70-20260831-01 · 70 mg vial · pH Solutions Lab · reported 29 September 2026 . The bar shows where the reported result falls against Astramide’s published release criterion. The notch marks the criterion.
Within criterion Above criterion Not on this COA
Test
Method
Criterion
Result
Result vs criterion
Status
Identity
Match to the labelled components
Match: GHK-Cu (C14H24CuN6O4, 403.9 g/mol), BPC-157 (C62H98N16O22, 1419.5 g/mol), TB-500 (C212H350N56O78S, 4963.4 g/mol)
WITHIN SPEC
Chromatographic purity
HPLC (220 nm)
at or above 99.0%
99%
95 at or above 99.0% 100
WITHIN SPEC
Net content (total)
70.7063 mg (101.009% of 70 mg nominal: GHK-Cu 50 mg, BPC-157 10 mg, TB-500 10 mg)
80 120
REPORTED
Appearance
Visual
blue to violet lyophilized powder
Blue to violet lyophilized powder cake, free of visible particulates
WITHIN SPEC
Water content
Karl Fischer
reported
0.6825%
WITHIN SPEC
pH
reported
7.0
WITHIN SPEC
Water activity
within laboratory limit
0.09 aw, pass
WITHIN SPEC
Microbial panel
not detected
Pass, 10 organisms and counts not detected in 1 g
WITHIN SPEC
Heavy metals
within laboratory limits
Pass. As, Cd, Pb, Hg each 0.000 ppm
WITHIN SPEC
Residual solvents
within laboratory limits
Pass, 12 solvents each 0.000 ppm
WITHIN SPEC
Sterility
sterile
Pass
WITHIN SPEC
Mycotoxins
within laboratory limits
Pass
WITHIN SPEC
Endotoxin
LAL
—
Not reported on this certificate
NOT REPORTED
Values are reported per vial unless otherwise noted. Every figure here is taken from the batch Certificate of Analysis and nothing else.
Certificate of Analysis
GLOW (BPC-157 + GHK-Cu + TB-500) Pro · Lot NHS-GLW70-20260831-01 · 70 mg vial · Lab No. NHS-GLW70-20260831-01
Download Full screen
Your browser cannot display the report inline. Open the PDF.
pH Solutions Lab · 4 pages · served inline, not a screenshot
Quick reference

How to read this report

Same six keys on every Astramide product page. Only the values change.
1Lot numberMatch it to the number printed on your vial. If they differ, this report is not for your vial.
2IdentityMass spectrometry confirms the molecule is the one on the label. It conforms or it does not. There is no partial result.
3Chromatographic purityThe share of the material that is the target peptide. A purity figure quoted without a method is not a purity figure.
4Net contentHow much peptide is in the vial, as measured by the laboratory. A different question from purity.
5EndotoxinMeasured against a ceiling, not a floor. Sensitivity differs by laboratory, so results are not compared across labs.
6Laboratory, method, dateWho ran it, on what instrument, and when. A report with no named laboratory or no date is not a report.
Molecular profile

GLOW (BPC-157 + GHK-Cu + TB-500) Pro, in structural terms.

Sequence
GHK-Cu: Gly-His-Lys, copper(II) complex BPC-157: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (GEPPPGKPADDAGLV) TB-500: thymosin beta-4 peptide
Structure type
Blend
Primary molecular target
No single shared target. Published research has examined GHK copper complexes in extracellular matrix studies, actin monomer binding by thymosin beta-4, and BPC-157 in a range of pre-clinical models.
Physical form
Lyophilized powder

GLOW is a lyophilized blend of three research peptides in one vial: GHK-Cu (50 mg), BPC-157 (10 mg) and TB-500 (10 mg), 70 mg in total. GHK-Cu is the copper(II) complex of the tripeptide Gly-His-Lys (C14H24CuN6O4, about 403.9 g/mol). BPC-157 is a 15-amino-acid peptide (GEPPPGKPADDAGLV, C62H98N16O22, about 1419.5 g/mol). TB-500 is identified on the current certificate as thymosin beta-4 (C212H350N56O78S, about 4963.4 g/mol). The blend is blue to violet because of the copper complex.

Research profile

Where GLOW (BPC-157 + GHK-Cu + TB-500) Pro appears in the literature.

Peptide Biology; Cell Biology; Cytoskeletal Biology; Extracellular Matrix Biology; Copper Peptide Chemistry
Research applications
  • Published studies have examined the individual components in:
  • GHK-Cu: copper peptide and extracellular matrix research
  • TB-500 (thymosin beta-4): actin monomer binding and sequestration
  • BPC-157: pre-clinical models, including nervous system research
  • No published study has examined the three-component blend itself.
Experimental systems
  • Fibroblast and extracellular matrix models (GHK-Cu)
  • Purified actin and cultured cell lines (thymosin beta-4)
  • Rodent models (BPC-157)
Specific assays
  • Extracellular matrix synthesis assays
  • Actin monomer binding assays
  • Copper binding studies
  • HPLC and mass spectrometry analysis of blend composition
Measured endpoints
  • Extracellular matrix component synthesis
  • Actin monomer sequestration
  • Copper(II) complex formation
  • Identity and content of each component in the blend
Pcs

Single Vial, Pack of 10
Strength

70mg
Mechanism and research context

What has been studied, and in what systems.

GLOW combines three peptides that have each been studied separately; no published study has examined the blend itself.

GHK is a naturally occurring tripeptide that binds copper(II), and the GHK-copper complex has been studied in extracellular matrix and tissue remodeling research (Pickart et al., 2008).

Thymosin beta-4 binds and sequesters actin monomers, holding them in an unpolymerized pool (Yu et al., 1993). BPC-157 is a 15-residue peptide that has been examined in a range of pre-clinical models, including nervous system research (Vukojevic et al., 2022).

These are published research systems. They do not describe approved clinical applications, and they do not establish efficacy or safety in humans.

Cited literature

Pickart L et al., 2008. The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed. PMID 18644225. https://pubmed.ncbi.nlm.nih.gov/18644225/
Yu FX et al., 1993. Thymosin beta 10 and thymosin beta 4 are both actin monomer sequestering proteins. J Biol Chem. PMID 8416954. https://pubmed.ncbi.nlm.nih.gov/8416954/
Vukojevic J et al., 2022. Pentadecapeptide BPC 157 and the central nervous system. Neural Regen Res. PMID 34380875. https://pubmed.ncbi.nlm.nih.gov/34380875/

Evidence level
Each component has its own pre-clinical literature, but no published study has examined the three-component blend. Statements on this page describe experimental systems for the individual components, not outcomes in humans.
Handling and storage
As supplied
Lyophilized powder in a sealed vial. Held in laboratory-rated freezers from arrival to shipment.
Storage
Store per the conditions printed on the vial label. Avoid heat, moisture and repeated temperature cycling.
Handling
For qualified professionals in controlled laboratory environments, following validated laboratory procedures.
Frequently asked questions

About this compound and its batch data.

What is GLOW peptide?

GLOW is a lyophilized research blend of three peptides in one vial: GHK-Cu (50 mg), BPC-157 (10 mg) and TB-500 (10 mg), 70 mg in total. The copper complex gives the powder a blue to violet colour. GLOW Pro is the Pro Series version, released under its own lot with its own certificate. Sold for research use only.

What has GLOW been examined for in published research?

No published study has examined the three-component GLOW blend itself. Its components have been studied separately: the GHK-copper complex in extracellular matrix research (Pickart et al., 2008, PMID 18644225), thymosin beta-4 in actin monomer sequestration (Yu et al., 1993, PMID 8416954) and BPC-157 in pre-clinical models. Astramide makes no claim about outcomes in humans.

What purity does the current GLOW Pro lot reach?

Lot NHS-GLW70-20260831-01 returned 99% chromatographic purity by HPLC at 220 nm, reported by pH Solutions Lab on 29 September 2026 under certificate 260911-899-NHS-17. Identity was confirmed for all three components: GHK-Cu, BPC-157 and TB-500. The lot meets the Pro Series release criterion of at or above 99% HPLC purity. The full certificate is published on this page.

How much peptide is in the GLOW Pro vial?

The nominal fill is 70 mg: GHK-Cu 50 mg, BPC-157 10 mg and TB-500 10 mg. For lot NHS-GLW70-20260831-01 the laboratory measured a combined net content of 70.7063 mg, which is 101.009% of nominal. This certificate reports content for the vial as a whole rather than for each component separately.

How should GLOW be stored for research use?

Lyophilized GLOW is stored at -20°C and protected from light. Once reconstituted, the solution is held at 2 to 8°C and used within 14 to 30 days. Repeated temperature cycling and exposure to moisture should be avoided, because both can affect peptide stability and the comparability of experimental results.

How is GLOW different from KLOW?

GLOW contains three peptides: GHK-Cu, BPC-157 and TB-500. KLOW contains the same three plus KPV, the Lys-Pro-Val tripeptide, for 80 mg in total. Each blend has its own lot numbers and its own certificates. A certificate for one blend never applies to the other, and each blend is tested as a blend.

How is Astramide's GLOW Pro tested?

Lot NHS-GLW70-20260831-01 was tested by pH Solutions Lab, an independent ISO/IEC 17025:2017 accredited laboratory (A2LA R243, PJLA Testing #84351). The certificate reports identity for each component, chromatographic purity at 220 nm, total net content, water content, pH, water activity, a 10-organism microbial panel, heavy metals, residual solvents, sterility and mycotoxins. Results apply only to this lot.

What is the difference between GLOW and GLOW Pro?

GLOW Pro is part of the Astramide Pro Series. It is American-made, synthesized in the USA, and moves by domestic ground and air only, with no ocean freight. It is released under its own lot, and only when HPLC purity measures at or above 99%. The full certificate for each lot is published on this page. The standard GLOW is released under separate lots with separate certificates.

Research use only

This product is intended strictly for in-vitro laboratory research conducted by qualified professionals. It is not intended for human or animal consumption, clinical use, or therapeutic application. The statements on this page have not been reviewed by the FDA. These research peptides are not intended to diagnose, treat, cure, or prevent any disease. Research Use Only.

COA library Every lot we have tested Search by batch number. Past lots stay published. How we test The analytical panel What each method measures and the criterion each lot must meet. Open Lab Send us your peptides Any vendor. Same lab. Your own Certificate of Analysis.
Ships from Austin, TexasUSPS or UPS, your choice
United States onlyFree shipping at $150 and over
Optional shipping insuranceAdded at checkout
Replacement or store creditOn approved claims. See refund policy.

Related products